transition bio limited
transition bio limited Company Information
Company Number
12747523
Next Accounts
Sep 2025
Shareholders
transition bio inc.
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
eastbrook shaftesbury road, cambridge, cambridgeshire, CB2 8DU
Website
-transition bio limited Estimated Valuation
Pomanda estimates the enterprise value of TRANSITION BIO LIMITED at £4.3m based on a Turnover of £3.1m and 1.41x industry multiple (adjusted for size and gross margin).
transition bio limited Estimated Valuation
Pomanda estimates the enterprise value of TRANSITION BIO LIMITED at £0 based on an EBITDA of £-4.9m and a 5.54x industry multiple (adjusted for size and gross margin).
transition bio limited Estimated Valuation
Pomanda estimates the enterprise value of TRANSITION BIO LIMITED at £0 based on Net Assets of £-11.2m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Transition Bio Limited Overview
Transition Bio Limited is a live company located in cambridgeshire, CB2 8DU with a Companies House number of 12747523. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in July 2020, it's largest shareholder is transition bio inc. with a 100% stake. Transition Bio Limited is a young, small sized company, Pomanda has estimated its turnover at £3.1m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Transition Bio Limited Health Check
Pomanda's financial health check has awarded Transition Bio Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
6 Weak
Size
annual sales of £3.1m, make it smaller than the average company (£4.3m)
- Transition Bio Limited
£4.3m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Transition Bio Limited
- - Industry AVG
Production
with a gross margin of 54.2%, this company has a comparable cost of product (54.2%)
- Transition Bio Limited
54.2% - Industry AVG
Profitability
an operating margin of -172.5% make it less profitable than the average company (-5.3%)
- Transition Bio Limited
-5.3% - Industry AVG
Employees
with 30 employees, this is below the industry average (54)
30 - Transition Bio Limited
54 - Industry AVG
Pay Structure
on an average salary of £83.2k, the company has an equivalent pay structure (£83.2k)
- Transition Bio Limited
£83.2k - Industry AVG
Efficiency
resulting in sales per employee of £102.7k, this is less efficient (£131.4k)
- Transition Bio Limited
£131.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Transition Bio Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 123 days, this is slower than average (62 days)
- Transition Bio Limited
62 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Transition Bio Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (30 weeks)
1 weeks - Transition Bio Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 336.8%, this is a higher level of debt than the average (52.5%)
336.8% - Transition Bio Limited
52.5% - Industry AVG
TRANSITION BIO LIMITED financials
Transition Bio Limited's latest turnover from December 2023 is estimated at £3.1 million and the company has net assets of -£11.2 million. According to their latest financial statements, Transition Bio Limited has 30 employees and maintains cash reserves of £418.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | 30 | 22 | 9 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Tangible Assets | 2,811,331 | 3,046,223 | 289,587 |
| Intangible Assets | |||
| Investments & Other | |||
| Debtors (Due After 1 year) | |||
| Total Fixed Assets | 2,811,331 | 3,046,223 | 289,587 |
| Stock & work in progress | |||
| Trade Debtors | |||
| Group Debtors | |||
| Misc Debtors | 1,514,268 | 2,122,292 | 227,342 |
| Cash | 418,136 | 305,794 | 397,250 |
| misc current assets | |||
| total current assets | 1,932,404 | 2,428,086 | 624,592 |
| total assets | 4,743,735 | 5,474,309 | 914,179 |
| Bank overdraft | |||
| Bank loan | |||
| Trade Creditors | 479,456 | 398,229 | 343,392 |
| Group/Directors Accounts | |||
| other short term finances | |||
| hp & lease commitments | |||
| other current liabilities | 15,494,956 | 11,010,620 | 1,869,504 |
| total current liabilities | 15,974,412 | 11,408,849 | 2,212,896 |
| loans | |||
| hp & lease commitments | |||
| Accruals and Deferred Income | |||
| other liabilities | |||
| provisions | |||
| total long term liabilities | |||
| total liabilities | 15,974,412 | 11,408,849 | 2,212,896 |
| net assets | -11,230,677 | -5,934,540 | -1,298,717 |
| total shareholders funds | -11,230,677 | -5,934,540 | -1,298,717 |
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | 429,534 | 216,738 | |
| Amortisation | |||
| Tax | |||
| Stock | |||
| Debtors | -608,024 | 1,894,950 | 227,342 |
| Creditors | 81,227 | 54,837 | 343,392 |
| Accruals and Deferred Income | 4,484,336 | 9,141,116 | 1,869,504 |
| Deferred Taxes & Provisions | |||
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | |||
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | |||
| Group/Directors Accounts | |||
| Other Short Term Loans | |||
| Long term loans | |||
| Hire Purchase and Lease Commitments | |||
| other long term liabilities | |||
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | 112,342 | -91,456 | 397,250 |
| overdraft | |||
| change in cash | 112,342 | -91,456 | 397,250 |
transition bio limited Credit Report and Business Information
Transition Bio Limited Competitor Analysis
Perform a competitor analysis for transition bio limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CB2 area or any other competitors across 12 key performance metrics.
transition bio limited Ownership
TRANSITION BIO LIMITED group structure
Transition Bio Limited has no subsidiary companies.
Ultimate parent company
TRANSITION BIO LIMITED
12747523
transition bio limited directors
Transition Bio Limited currently has 4 directors. The longest serving directors include Mr Samuel Cohen (Jul 2020) and Mr Martin Kulander (Jun 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Samuel Cohen | United Kingdom | 38 years | Jul 2020 | - | Director |
| Mr Martin Kulander | United Kingdom | 34 years | Jun 2023 | - | Director |
| Professor Tuomas Knowles | United Kingdom | 45 years | Jun 2023 | - | Director |
| Mr George Martin | Usa | 66 years | Jul 2024 | - | Director |
P&L
December 2023turnover
3.1m
+33%
operating profit
-5.3m
0%
gross margin
54.2%
+2.21%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-11.2m
+0.89%
total assets
4.7m
-0.13%
cash
418.1k
+0.37%
net assets
Total assets minus all liabilities
Similar Companies
transition bio limited company details
company number
12747523
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
July 2020
age
5
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
eastbrook shaftesbury road, cambridge, cambridgeshire, CB2 8DU
Bank
-
Legal Advisor
-
transition bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to transition bio limited.
transition bio limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TRANSITION BIO LIMITED. This can take several minutes, an email will notify you when this has completed.
transition bio limited Companies House Filings - See Documents
| date | description | view/download |
|---|
